BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis, and evaluation of novel kazusamycin A derivatives as potent antitumor agents. 2006

Ryoichi Ando, and Yusaku Amano, and Hideo Nakamura, and Noriyoshi Arai, and Isao Kuwajima
Discovery Technology Laboratory II, Mitsubishi Pharma Corporation, 1000 Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan. Ando.Ryoichi@mk.m-pharma.co.jp

Novel kazusamycin A derivatives were designed in the viewpoint of decrease of reactivity at the alpha,beta-unsaturated delta-lactone moiety against Michael-type addition. Although 25-30 steps were required for the synthesis of each compound, their syntheses were achieved. Cytotoxicity against HPAC cell line was evaluated, and two of them exhibited comparable potency to kazusamycin A. Hepatic toxicity of these designed compounds was much lower than that of kazusamycin A.

UI MeSH Term Description Entries
D005231 Fatty Acids, Unsaturated FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds. Fatty Acids, Polyunsaturated,Polyunsaturated Fatty Acid,Unsaturated Fatty Acid,Polyunsaturated Fatty Acids,Acid, Polyunsaturated Fatty,Acid, Unsaturated Fatty,Acids, Polyunsaturated Fatty,Acids, Unsaturated Fatty,Fatty Acid, Polyunsaturated,Fatty Acid, Unsaturated,Unsaturated Fatty Acids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Ryoichi Ando, and Yusaku Amano, and Hideo Nakamura, and Noriyoshi Arai, and Isao Kuwajima
Design, synthesis, and antitumor activity of novel podophyllotoxin derivatives as potent anticancer agents.
September 2013, Journal of Asian natural products research,
Ryoichi Ando, and Yusaku Amano, and Hideo Nakamura, and Noriyoshi Arai, and Isao Kuwajima
Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition.
November 2020, Bioorganic chemistry,
Ryoichi Ando, and Yusaku Amano, and Hideo Nakamura, and Noriyoshi Arai, and Isao Kuwajima
Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents.
July 2003, Journal of medicinal chemistry,
Ryoichi Ando, and Yusaku Amano, and Hideo Nakamura, and Noriyoshi Arai, and Isao Kuwajima
Design, synthesis and biological evaluation of novel homocamptothecin analogues as potent antitumor agents.
May 2015, Bioorganic & medicinal chemistry,
Ryoichi Ando, and Yusaku Amano, and Hideo Nakamura, and Noriyoshi Arai, and Isao Kuwajima
Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine and quinazoline derivatives as potent antitumor agents.
September 2019, Bioorganic chemistry,
Ryoichi Ando, and Yusaku Amano, and Hideo Nakamura, and Noriyoshi Arai, and Isao Kuwajima
Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
September 2014, Bioorganic & medicinal chemistry letters,
Ryoichi Ando, and Yusaku Amano, and Hideo Nakamura, and Noriyoshi Arai, and Isao Kuwajima
Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agents.
April 2014, European journal of medicinal chemistry,
Ryoichi Ando, and Yusaku Amano, and Hideo Nakamura, and Noriyoshi Arai, and Isao Kuwajima
Design and Synthesis of Biotinylated Bivalent Carboline Derivatives as Potent Antitumor Agents.
September 2020, The Journal of organic chemistry,
Ryoichi Ando, and Yusaku Amano, and Hideo Nakamura, and Noriyoshi Arai, and Isao Kuwajima
Synthesis and activity evaluation of phenylurea derivatives as potent antitumor agents.
June 2009, Bioorganic & medicinal chemistry,
Ryoichi Ando, and Yusaku Amano, and Hideo Nakamura, and Noriyoshi Arai, and Isao Kuwajima
Synthesis and biological evaluation of baicalein derivatives as potent antitumor agents.
March 2014, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!